Efficacy of Telemetry-assisted Care in Home Home Vented COPD

Launched by GEORG NILIUS, PROF DR MED · Mar 10, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how effective telemonitoring is for patients with Chronic Obstructive Pulmonary Disease (COPD) who use a non-invasive ventilation (NIV) device at home. The goal is to see if using technology to monitor patients' breathing can help them stick to their treatment plan better and reduce the chances of needing to go to the hospital. Patients will receive personalized support when their symptoms worsen or if there are issues with their ventilation settings.

To participate in this study, individuals need to be between the ages of 65 and 74 and either new to using NIV or returning to it after a break of at least three months. They must also agree to participate by signing consent forms. It's important to note that those who cannot give consent, have certain medical conditions that prevent them from using NIV, or are involved in other related studies won't be eligible. Participants can expect regular monitoring of their treatment and tailored support to help manage their COPD more effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • NIV-naive / Continuation after 3 Months Interruption
• • Indication for initiation of NIV according to S2k guideline of the German Society of Pneumology
• • Presence of the signed informed consent
• Exclusion Criteria:
• • Absence of signed written informed consent for data protection and study participation.
• • contraindication to PAP therapy
• • Participation in another study that influences the setting of NIV therapy through specifications regarding device settings or titration